Unknown

Dataset Information

Strategies for isoniazid preventive therapy in HIV-positive patients who consume alcohol.


ABSTRACT: BACKGROUNDWHO guidance to defer isoniazid preventive therapy (IPT) among those with regular alcohol use because of hepatotoxicity concerns may exclude many people living with HIV (PLWH) at high TB risk in these settings.OBJECTIVETo evaluate hepatotoxicity during TB preventive therapy (TPT) in PLWH who report alcohol use in Uganda over 10 years.METHODSWe developed a Markov model of latent TB infection, isoniazid preventive therapy (IPT - a type of TPT), and TB disease using data from the Alcohol Drinkers' Exposure to Preventive Therapy for TB (ADEPTT) study. We modeled several treatment scenarios, including no IPT, IPT with liver enzyme monitoring (AST/ALT) during treatment, and IPT with pre-screening using the tubercul

SUBMITTER: Savinkina A 

PROVIDER: S-EPMC11875055 | biostudies-literature | 2024 Jul

REPOSITORIES: biostudies-literature